In Simple Terms
A drug known for causing hallucinations seemed to help mouse brain cells make and keep new connections. The effect depended on whether the brain was already under stress, and the brain changes could be separated from a mouse behavior linked to the drug’s hallucinatory effects. This does not prove the drug will help people, but it points to new questions for researchers.
A Window onto the Brain’s Smallest Connections
A psychedelic drug’s effects on the brain might seem like one broad wave of activity. But changes inside neural circuits can be more selective and complex. In a study of mice, researchers tracked tiny contact points between brain cells after giving the animals psilocybin. They found that the drug did more than prompt new connections to form: its effects also depended on the brain’s condition, and could be separated from a behavioral response used in rodents as an indicator of hallucinatory effects.
The study was led by researchers at the University of California, Santa Cruz, and published in Nature Neuroscience on October 1, 2026. The authors included Jacob Baker, Emily Cogan, Xiaorong Ma, Joe Lo, and Yi Zhou. Rather than examining brain tissue only after the experiment was over, the team used two-photon microscopy to observe changes in the brains of living mice over several weeks.
The researchers focused on dendritic spines: tiny protrusions on the branches of nerve cells that receive many of the signals sent by other cells. These structures can be thought of as changeable contact points. New spines can appear, existing connections can disappear, and some spines change shape as they grow and become more stable. Tracking each structure individually allowed the researchers to follow changes over time instead of relying on a general average that might conceal differences among connections.
Within the first 24 hours after the mice received psilocybin, the researchers saw a clear increase in the formation of new spines. But the change was not just about the number of spines. The team also observed that some newly formed protrusions shifted more quickly from a short, less stable shape into a larger, mushroom-like form. This more mature structure is associated with components that support a connection and with receptors that receive chemical messages between nerve cells, including AMPA receptors.
A new connection does not automatically last or settle into a stable role. That is why following the fate of each spine matters. The team’s results suggest that some connections formed after psilocybin matured and remained for weeks. This helps distinguish lasting structural change from a temporary increase in cell protrusions. Still, the researchers cannot yet say what each of these structures means for brain function or behavior.
The Brain Does Not Respond the Same Way in Every Condition
One of the study’s most striking findings was that psilocybin did not indiscriminately multiply connections in every situation. The pattern of change depended on the brain’s condition before treatment. In healthy mice, the rate of new spine formation increased, but some pre-existing connections were also removed over the following three weeks. The result was not an unlimited, ongoing buildup. Instead, the brain both formed new connections and pruned others.
One way to understand this balance is that neural circuits do not always need as many connections as possible. Adding new connections while keeping every old one may not be the most suitable response. Reshaping the network by changing what is added and what is removed may be part of how the brain regulates itself. But this study measured structural changes in mice, and on its own it cannot show how that balance affects human thought or mood.
The team also studied mice exposed to chronic, unpredictable, mild stress, an experimental model used to investigate some features of stress and disrupted neural connections. In these animals, stress was associated with the ongoing loss of some synapses. After the mice received psilocybin, the surge in new spine formation was greater than the one seen in unstressed mice. The drug also halted the excess loss of existing connections during the experiment.
This comparison does not mean the drug restores everything damaged by stress, nor does it prove that treatment for depression in people will work in the same way. But it suggests that the brain’s starting condition matters: a damaged neural circuit may not respond like a healthy one. The results also challenge the idea that psilocybin acts like a switch that raises neural connectivity everywhere in the same way. Instead, the pattern the researchers observed varied with the condition of the circuit before the experiment began.
An Experiment Separates Brain Remodeling from a Hallucination-Linked Sign
The researchers then turned to a different question: Do the brain’s structural changes require activation of the same mechanism associated with hallucinatory effects? They focused on serotonin 2A receptors, commonly called 5-HT2A, in pyramidal cells in layer five of the cerebral cortex. These cells are part of the circuits that carry signals out of the cortex. The study, however, tested the role of these receptors in this particular cell type, not in every cell in the brain.
The team used targeted genetic modifications to change whether these cells had the receptors, then compared spine formation and maturation with the mice’s head-twitch response. This behavior is used in rodent research as an experimental indicator of effects associated with hallucinations. It is not a report of a conscious experience, and it should not be treated as directly equivalent to what a person describes when talking about hallucinations.
When the researchers restored 5-HT2A receptors specifically in layer-five pyramidal cells, psilocybin was able to promote spine formation and maturation even though the mice did not show the head-twitch response. When the receptors were removed from those cells, the structural change the team was tracking did not appear, while the head-twitch response remained. In other words, the genetic manipulation separated two pathways: one linked to the remodeling of connections in these cells, and another whose behavioral sign could still appear without the receptors in those cells.
This kind of result is sometimes called a double dissociation. By changing the same factor in two different ways and seeing different effects, researchers can show that one phenomenon does not simply depend on the other. In this study, activating serotonin 2A receptors in layer-five cells was both necessary and sufficient for the synaptic remodeling the researchers measured, but it was not necessary for the head-twitch behavior. That does not mean the team has established a ready-to-use non-hallucinogenic treatment. Rather, it has identified a cellular mechanism that could help guide the search for one.
What Could the Findings Mean for Treatment?
Psilocybin is being studied as part of psychological treatments, including for forms of depression that are difficult to treat. But moving from a result in mice to a clinical benefit in people requires independent evidence. This experiment observed changes in the structure of neural connections, used a stress model, and measured a behavioral response in rodents. It did not test treatment in patients or compare clinical outcomes in people. The findings should therefore not be read as proof that the growth of new spines alone is enough to ease depression symptoms.
Even so, the results raise an important possibility for drug research. If scientists can understand the signals that prompt cells to form and mature new connections, it may become possible to develop compounds that encourage structural flexibility without producing hallucinatory effects. That remains a research possibility, not an available drug or a proven clinical outcome. And finding receptors that matter in one cell type is only one step. Any potential compound would still need to be tested for safety and effectiveness, its effects on different brain functions would need to be established, and its results would have to be confirmed in controlled human trials.
The study is also valuable because it provides a timeline that a single measurement after treatment could not capture. Seeing new spines appear within 24 hours, then following the maturation of some of them and their persistence for weeks, allows researchers to ask questions about the stages of the response. What sets the change in motion? Which connections become stable? And why does the balance between adding and removing connections differ in a stressed brain? The results do not answer all these questions, but they make them testable through direct observation of neural structures.
The work was supported by the National Institute of Mental Health and the National Institute on Aging in the United States. Psilocybin was provided through the National Institute on Drug Abuse’s drug supply program. These details place the study within basic research that combines live imaging with genetic manipulation to explain underlying mechanisms before drawing conclusions about possible applications. The limits are important: a mouse is not a complete model of human psychological experience, and the head-twitch response is not a direct measure of awareness or perception.
The Bottom Line
The University of California, Santa Cruz, study offers a more detailed picture of how psilocybin may affect neural connections: the number of new spines increased within 24 hours, some matured and remained for weeks, and the balance between adding and removing connections shifted depending on whether the brain was healthy or affected by chronic stress. Genetic experiments also showed that remodeling connections in cortical layer-five cells could be separated from the head-twitch response in mice. The work is a step toward understanding a possible mechanism and designing future research, not definitive evidence of a treatment for people. Establishing safety and benefit will require direct clinical trials.